Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01282112 · ClinicalTrials.gov registry record
Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 416
- Enrollment target
NCT01282112: Completed study, sponsored by Akron Children's Hospital.
NCT01282112 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 416 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01282112 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 416 participants
- Enrollment target
Study Summary
This is a retrospective chart review study (700 charts from 2002 to 2010)of children from 0 to 18 years of age who have undergone Brainstem Evoked Auditory Response (BEAR)testing using midazolam and pentobarbital protocol for moderate sedation. The specific aims of this study are two-fold: 1. to determine the efficacy of intravenous pentobarbital during BEAR testing in the pediatric population using a standardized protocol; and 2. to evaluate the incidence of adverse events (major and minor), paradoxical reaction and failed sedation and identify predictors for failure and adverse events if any.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-07 |
What the finished NCT01282112 record still lists
NCT01282112 is an observational study that tracks outcomes without assigning an intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01282112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01282112 about?
NCT01282112 is a clinical study titled "Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital". This is a retrospective chart review study (700 charts from 2002 to 2010)of children from 0 to 18 years of age who have undergone Brainstem Evoked Auditory Response (BEAR)testing using midazolam and pentobarbital protocol for moderate sedation. The specific aims of this study are two-fold: 1. to de...
What is the current status of trial NCT01282112?
This trial is currently completed. The enrollment target is 416 participants. The study started on 2011-01. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01282112?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia